Westlake Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $14.6M

  • Investors
  • 18

Westlake Therapeutics General Information

Description

Developer of engineered red blood cell therapies designed to advance treatment for cancer, immune disorders, and rare diseases. The company offers a proprietary REDx drug-conjugation method and a diverse pipeline including antibody and mRNA therapies, enabling healthcare researchers and clinicians to develop safer, targeted medicines for patients in need.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 202, Building 1, Number 1 Yunmeng Road, Zhuantang Street
  • Xihu District
  • Hangzhou, Zhejiang 200131
  • China
+86 0571
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 202, Building 1, Number 1 Yunmeng Road, Zhuantang Street
  • Xihu District
  • Hangzhou, Zhejiang 200131
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Westlake Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 17-Apr-2026 $14.6M Completed Generating Revenue
6. Early Stage VC (Series A1) 26-Jun-2022 Completed Generating Revenue
5. Secondary Transaction - Private 06-Aug-2021 Completed Generating Revenue
4. Early Stage VC 15-Jul-2021 Completed Generating Revenue
3. Early Stage VC 07-Mar-2021 Completed Generating Revenue
2. Early Stage VC 19-Jan-2021 $15.4M $29.5M Completed Generating Revenue
1. Early Stage VC 26-May-2020 $14.1M $14.1M Completed Generating Revenue
To view Westlake Therapeutics’s complete valuation and funding history, request access »

Westlake Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of engineered red blood cell therapies designed to advance treatment for cancer, immune disorders, and rare di
Drug Discovery
Hangzhou, China
2 As of 2019

Cambridge, MA
 

Richmond, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Westlake Therapeutics Competitors (3)

One of Westlake Therapeutics’s 3 competitors is Carmine Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carmine Therapeutics Venture Capital-Backed Cambridge, MA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Plasticell Venture Capital-Backed London, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Westlake Therapeutics Patents

Westlake Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020227885-A1 Genetically engineered red blood cells carrying anti-pd-1 single-chain antibody and preparation method therefor Inactive 10-May-2019
WO-2020172915-A1 Method for using peripheral blood for in-vitro preparation of mature red blood cells, and preparation Inactive 28-Feb-2019

Westlake Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Westlake Therapeutics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Taiping Guofa Hehe (Beijing) Investment Management Growth/Expansion Minority
Ao Peng Investment PE/Buyout Minority
Guangzhou Tiancheng Capital Management Group Venture Capital Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Westlake Innovation (Hangzhou) Private Equity Fund Management Growth/Expansion Minority
You’re viewing 5 of 18 investors. Get the full list »

Westlake Therapeutics FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process